Common Contracts
2 similar Shared Care Agreement contracts
EFFECTIVE SHARED CARE AGREEMENT OF SULFASALAZINE PLAIN AND ENTERIC COATED (EC) FOR THE TREATMENT OF ULCERATIVE COLITIS / CROHN’S DISEASE & AUTOIMMUNE RHEUMATIC DISEASES (EC only)Shared Care Agreement • February 8th, 2021
Specialist clinicians responsibilities 1 Discuss the benefits and side effects of treatment with the patient.2 Check for possible drug interactions with sulfasalazine and patient’s regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient is given sufficient information about their treatment.5 Perform all baseline tests (including FBC, U&Es and LFTs).6 Initiate and stabilise treatment with sulfasalazine. Stabilisation will usually take 7 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirements.10 Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist clinician.11 Ensure GP has access to blood results for information.12 Monitor for side effects and
EFFECTIVE SHARED CARE AGREEMENT OF SULFASALAZINE PLAIN AND ENTERIC COATED (EC) FOR THE TREATMENT OF ULCERATIVE COLITIS / CROHN’S DISEASE & AUTOIMMUNE RHEUMATIC DISEASES (EC only)Shared Care Agreement • July 23rd, 2020
Specialist clinicians responsibilities 1 Discuss the benefits and side effects of treatment with the patient.2 Check for possible drug interactions with sulfasalazine and patient’s regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient is given sufficient information about their treatment.5 Perform all baseline tests (including FBC, U&Es and LFTs).6 Initiate and stabilise treatment with sulfasalazine. Stabilisation will usually take 7 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirements.10 Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist clinician.11 Ensure GP has access to blood results for information.12 Monitor for side effects and
